Assessing the spatio-temporal risk of Aedes-borne arboviral diseases in non-endemic regions: The case of Northern Spain.

Assessing the spatio-temporal risk of Aedes-borne arboviral diseases in non-endemic regions: The case of Northern Spain.

Publication date: Jul 28, 2025

Arboviral diseases represent a growing global health challenge. While dengue cases surge in endemic regions, non-endemic areas in southern Europe are seeing a rise in imported cases of dengue, Zika, and chikungunya, along with the first autochthonous dengue transmissions. The expanding Aedes mosquito populations, influenced by climate change, and increased international travel introducing viremic cases further elevate the risk of outbreaks. These trends emphasize the urgent need for effective risk assessment and timely intervention strategies. We present a data-driven methodology to assess the spatio-temporal risk of Aedes-borne arboviral diseases in non-endemic settings, addressing key limitations of models developed primarily for endemic regions and challenges related to limited data availability. Our approach builds on the SIRUVY human-vector compartmental model and incorporates stochastic formulations to capture variability in imported cases and mosquito density – two critical drivers of autochthonous transmission and outbreak emergence. This framework improves risk estimation and offers insights into transmission dynamics in regions where outbreaks are rare and unpredictable, shaped by sporadic case importations and a non-persistent vector presence. Using data from the Basque Country (2019-2023), including Aedes mosquito egg counts as a proxy for vector abundance and records of imported cases, we mapped the monthly risk of local transmission at the municipal level and conducted a scenario-based risk assessment aligned with Spain’s entomological classification. Our findings indicate a growing presence of Aedes mosquitoes and an increasing transmission risk in urban and peri-urban areas of the Basque Country, revealing shifting hotspots of possible arboviral disease transmission. These results highlight the importance of sustained surveillance to identify high-risk locations and prioritize targeted public health interventions to prevent potential outbreaks.

Open Access PDF

Concepts Keywords
Dengue Aedes
Europe Arboviral
Mosquitoes Dengue
Surveillance Diseases
Endemic
Imported
Mosquito
Non
Outbreaks
Regions
Risk
Spatio
Temporal
Transmission
Vector

Semantics

Type Source Name
disease MESH dengue
disease IDO intervention
disease MESH autochthonous transmission
disease IDO country
drug DRUGBANK Ranitidine
disease IDO history
disease IDO process
pathway REACTOME Reproduction
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Trestolone
disease MESH Neglected Tropical Diseases
disease MESH Aedes borne diseases
disease MESH vector borne diseases
disease IDO pathogen
disease MESH infections
disease IDO infection
disease IDO quality
drug DRUGBANK Coenzyme M
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH COVID 19 pandemic
disease IDO vector surveillance
disease IDO site
disease IDO algorithm
drug DRUGBANK Tretamine
disease MESH death
disease IDO entity
drug DRUGBANK Cysteamine
drug DRUGBANK Ademetionine
disease MESH infectious diseases
drug DRUGBANK Medical air
drug DRUGBANK Trihexyphenidyl
disease MESH malaria
pathway KEGG Malaria
disease IDO virulence
drug DRUGBANK O1-Methyl-Glucose
drug DRUGBANK Flunarizine
disease MESH reinfection
disease MESH dengue hemorrhagic fever

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *